In-depth resources on patient tracking, follow-up workflow management, and preventing patients from falling through the cracks.
MAMMOTRACK
Breast Imaging News
Loading breast imaging news…
Resources
Knowledge That Moves Breast Imaging Forward
A growing library of practical insights, guides, and operational resources to help imaging centers improve follow-up, strengthen compliance, and make smarter decisions with confidence.
Guides on lay communication letters, patient notification workflows, MQSA communication requirements, and outreach best practices.
MAMMOCOMMUNICATE
Resources for breast imaging navigators — follow-up coordination, 30-60-90 day models, patient support, and closing care gaps.
MAMMONAVIGATE
Practical guidance on MQSA compliance, accreditation-related reporting, audit preparation, and documentation that stands up to review.
MAMMOCOMPLY
A curated archive of white papers, manuals, guidance documents, and research references for breast imaging professionals. Browse in-browser.
MAMMOLIBRARY
Your central hub for mammography calculators, compliance resources, policy tools, and practice guides.
MAMMOTOOLBOX
A central resource for insights, guidance, and practical breast imaging support.
KNOWLEDGE HUB
Real-world stories from breast imaging facilities — anonymized accounts of how tracking, follow-up, communication, and compliance challenges unfold in practice.
BEYOND THE MAMMOGRAM
Home of BINA Voices: Bridging Care, Knowledge & Support in Breast Imaging — the podcast from the Breast Imaging Navigation Alliance, supported by Mammologix.
MAMMOSTUDIO
Short video resources on breast imaging workflow, MQSA compliance, patient follow-up, and Mammologix operational support in action.
VIDEO LIBRARY
Knowledge Base
Latest Articles
The Knowledge HubIn-Depth
MQSA: The Unlikely Birth of the Only Imaging Modality with Real Federal Teeth
In 1992, the Mammography Quality Standards Act became the only federal law mandating quality oversight for a single diagnostic imaging modality. This is how Betty Ford's candor, failed voluntary accreditation, and congressional urgency combined to create the regulatory framework that still governs every mammography facility in the country.
Aug 22, 20265 min read
The Knowledge HubStandard Read
What Is Breast Density?
Breast density describes the relative proportion of fibroglandular to fatty tissue visible on a mammogram. It simultaneously lowers mammographic sensitivity through a masking effect and functions as an independent risk factor for breast cancer. As of September 10, 2024, the MQSA Final Rule requires every facility to report density using a standardized four-category lexicon and include prescribed notification language in every patient lay letter.
Aug 20, 20265 min read
MammoCommunicateStandard Read
What Is a Lay Result Letter in Mammography?
The Mammography Quality Standards Act requires every certified facility to send each patient a plain-language results letter within 30 calendar days -- or within 7 days when findings are Suspicious or Highly Suggestive of Malignancy. The 2023 Final Rule, effective September 10, 2024, added mandatory breast density classification and exact FDA-prescribed notification language that facilities may not alter. This article covers what the letter must contain, how it differs from the technical report, and the evidence-based design principles that determine whether patients act on their results.
Aug 20, 20265 min read
The Knowledge HubIn-Depth
What Is “Lost to Follow-Up” in Mammography?
Lost to follow-up (LTFU) is the operational state in which a patient with an unresolved positive mammogram assessment can no longer be reached after documented outreach has been exhausted. This article defines LTFU, distinguishes it from the earlier overdue state, quantifies its audit impact under MQSA, and outlines the closed-loop tracking architecture required to minimize its occurrence.
Aug 19, 20267 min read
The Knowledge HubIn-Depth
What Is DCIS (Ductal Carcinoma In Situ)?
Ductal carcinoma in situ (DCIS) is a stage 0, noninvasive proliferation of abnormal cells confined within breast ducts. It is both a clinical entity with a non-obligate progression pathway to invasive cancer and a high-stakes audit outcome under MQSA. This article covers definition, epidemiology, diagnosis, treatment, and the operational closed-loop tracking requirements every facility must meet.
Aug 19, 20269 min read
The Knowledge HubIn-Depth
What Is PPV in Mammography? PPV1, PPV2, and PPV3 Explained
PPV in mammography is measured at three distinct clinical stopping points. Learn how PPV1, PPV2, and PPV3 expose different operational failures in the breast imaging audit pathway under FDA-MQSA and ACR BI-RADS requirements.
Aug 18, 20269 min read
The Knowledge HubIn-Depth
Downstream Revenue Estimator: Methods and Validation Note
A complete, reproducible documentation of the Downstream Revenue Estimator's arithmetic: the three-tier revenue formulas, two-population detection logic, treatment blending, largest-remainder display rounding, a worked year-1 example, and the full 420-configuration validation matrix.
Aug 17, 20268 min read
MammoComplyStandard Read
The Role of Breast Imaging in Multidisciplinary Excellence: Record-Keeping, Monitoring, Auditing, and Reporting Functions Under the NAPBC
Breast imaging is a core structural element of NAPBC accreditation, not a downstream service. Standards 3.3, 3.4, 5.1, 5.2, 5.4, 5.6, 2.4, and 7.2 require specific record-keeping, monitoring, auditing, and reporting functions that convert imaging output into verifiable, auditable patient pathways.
Aug 17, 20269 min read
MammoTrackStandard Read
Tracking-Surveillance in Medical Mammography Quality Auditing
Tracking is not compliance paperwork -- it is the closed-loop feedback mechanism that measures interpretive accuracy, identifies care gaps, and creates the conditions under which early-stage cancers are found before they progress. Here is what the MQSA floor requires and what robust surveillance adds.
Aug 17, 20267 min read
MammoTrackStandard Read
Overdue and Lost to Follow-Up as Distinct States: Operational Implications for the Medical Outcomes Audit, Tracking Architecture, and Closed-Loop Navigation
Overdue and lost to follow-up are not interchangeable labels -- they are distinct operational states with different intervention capacity, audit implications, and navigation consequences. Keeping them separate is the foundation of any MQSA-compliant tracking system.
Aug 17, 20268 min read
The Knowledge HubIn-Depth
Estimating What Follows the Mammogram: A Transparent Model of Breast Imaging Downstream Revenue
A screening mammogram begins a pathway, not ends one. The Downstream Revenue Estimator by Mammologix models the full revenue picture of a mammography program across a multi-year horizon -- from base screening through diagnostic workup, biopsy, detection, and treatment -- with cited defaults and every assumption adjustable.
Aug 17, 202612 min read
MammoCommunicateStandard Read
The 30-60-90 Day Letter Protocol: How Continual Written Outreach Improves Mammography Follow-Up
A structured 30-60-90 day written outreach sequence moves more patients to follow-up imaging after an abnormal mammogram -- even without telephone contact. Each successive letter grows more specific through technology, and adding human interaction raises compliance still further.
Aug 17, 20266 min read
Didn't find what you were looking for?
Our team has supported breast imaging centers since 1995. If it's not here, we probably know the answer.